Over-treatment in metastatic breast cancer

详细信息    查看全文

• 作者：Elżbieta Senkus^a ; ^{elsenkus@gumed.edu.pl} ; Aleksandra Łacko^b ; ^{olalacko@wp.pl}
• 关键词：Breast cancer ; Metastatic ; Chemotherapy ; Endocrine therapy ; Targeted therapy ; Overtreatment
• 刊名：The Breast
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：31
• 期：Complete
• 页码：309-317
• 全文大小：356 K
• 卷排序：31

文摘

MBC is incurable and treatment goals are to prolong life and improve its quality. In ER+ tumours antitumor effect can be often achieved by endocrine therapy. In HER2+ cancers efficacy of backbone therapy can be enhanced by anti-HER2 agent. In patients requiring chemotherapy consecutive single agent regimen are preferred. Aggressive chemotherapy is still overused in many MBC patients.